Patents by Inventor Stanley J. Alkemade

Stanley J. Alkemade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10004773
    Abstract: The disclosure provides compositions containing preparations from plants of the family Marcgraviaceae and from plants of the family Platanaceae. The disclosure also provides methods and uses of plant preparations for treating anxiety, stress and glucocorticoid related disorders.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: June 26, 2018
    Assignee: University of Ottawa
    Inventors: Tony Durst, John Douglas Baker, John Thor Arnason, Jose Miguel Wade, Zulfiquar Merali, Martha Mullally, Christian Cayer, Stanley J. Alkemade, Ana Francis Carballo, Iqubal Velji
  • Publication number: 20150283190
    Abstract: The disclosure provides compositions containing preparations from plants of the family Marcgraviaceae and from plants of the family Platanaceae. The disclosure also provides methods and uses of plant preparations for treating anxiety, stress and glucocorticoid related disorders.
    Type: Application
    Filed: November 8, 2013
    Publication date: October 8, 2015
    Inventors: Tony Durst, John Douglas Baker, John Thor Arnason, Jose Miguel Wade, Zulfiquar Merali, Martha Mullally, Christian Cayer, Stanley J. Alkemade, Ana Francis Carballo, Iqubal Velji
  • Patent number: 7985432
    Abstract: The invention provides compositions and methods useful in repelling target pests, such as insects from target areas. The compositions comprise mixtures or solutions of at least one repellent composition. The compositions of the invention preferably include an effective amount of evening primrose oil (“EPO”) to repel a target pest from a target area, such as animals, humans, plants or building structures, along with a carrier. The repellent composition may include a combination of EPO with another plant extract oil and a combination of EPO with catnip oil, optionally combined with another plant extract oil. The method for repelling target pests from animals comprises contacting a target area with the repellent composition to repel the target pest from the target area. The method also reduces transmission of infectious diseases transmitted by target pests by reducing contact of the pest with target areas.
    Type: Grant
    Filed: May 12, 2008
    Date of Patent: July 26, 2011
    Assignee: Bioniche Life Sciences, Inc.
    Inventors: John D. Baker, John T. Arnason, Calum McRae, Jose M. Wade, Stanley J. Alkemade
  • Publication number: 20080213408
    Abstract: The invention provides compositions and methods useful in repelling target pests, such as insects from target areas. The compositions comprise mixtures or solutions of at least one repellent composition. The compositions of the invention preferably include an effective amount of evening primrose oil (“EPO”) to repel a target pest from a target area, such as animals, humans, plants or building structures, along with a carrier. The repellent composition may include a combination of EPO with another plant extract oil and a combination of EPO with catnip oil, optionally combined with another plant extract oil. The method for repelling target pests from animals comprises contacting a target area with the repellent composition to repel the target pest from the target area. The method also reduces transmission of infectious diseases transmitted by target pests by reducing contact of the pest with target areas.
    Type: Application
    Filed: May 12, 2008
    Publication date: September 4, 2008
    Applicant: Bioniche Life Sciences, Inc.
    Inventors: John D. Baker, John T. Arnason, Calum McRae, Jose M. Wade, Stanley J. Alkemade
  • Patent number: 7381431
    Abstract: The invention provides compositions and methods useful in repelling target pests, such as insects from target areas. The compositions comprise mixtures or solutions of at least one repellent composition. The compositions of the invention preferably include an effective amount of evening primrose oil (“EPO”) to repel a target pest from a target area, such as animals, humans, plants or building structures, along with a carrier. The repellent composition may include a combination of EPO with another plant extract oil and a combination of EPO with catnip oil, optionally combined with another plant extract oil. The method for repelling target pests from animals comprises contacting a target area with the repellent composition to repel the target pest from the target area. The method also reduces transmission of infectious diseases transmitted by target pests by reducing contact of the pest with target areas.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: June 3, 2008
    Assignee: Bioniche Life Sciences, Inc.
    Inventors: John D. Baker, John T. Arnason, Calum McRae, Jose M. Wade, Stanley J. Alkemade
  • Patent number: 6139844
    Abstract: A method for treating or eliminating a protozoal or parasitic disease in an animal in which a sufficient amount of a bacterial cell wall extract is administered to the animal having the protozoal or the parasitic disease. The cell wall extract is preferably a mycobacterial cell wall extract or a cornybacterium cell wall extract. The cell wall extract is most preferably a Mycobacterium phlei cell wall extract.
    Type: Grant
    Filed: April 2, 1998
    Date of Patent: October 31, 2000
    Assignee: Bioniche, Inc.
    Inventors: Stanley J. Alkemade, Catherine E. Hildebrand, Nigel C. Phillips, Dragan R. Rogan
  • Patent number: 5888986
    Abstract: A method of treating interstitial cystitis comprising contacting the transitional epithelium lining the urinary bladder and associated structures in a mammal having interstitial cystitis with a solution containing hyaluronic acid having a average molecular weight of not less than 2.times.10.sup.5 Daltons in a concentration effective to treat the interstitial cystitis.
    Type: Grant
    Filed: May 13, 1996
    Date of Patent: March 30, 1999
    Assignee: Bioniche Inc.
    Inventors: Alvaro Morales, Stanley J. Alkemade
  • Patent number: 5880108
    Abstract: A method of treating cystitis comprising contacting the urinary bladder and associated structures in a mammal having cystitis with a solution containing hyaluronic acid having a average molecular weight of not less than 2.times.10.sup.5 Daltons in a concentration effective to treat the cystitis. The solution may further contain an agent effective to treat the associated cause of the cystitis in a concentration effective to treat the associated cause of the cystitis.
    Type: Grant
    Filed: March 26, 1997
    Date of Patent: March 9, 1999
    Assignee: Bioniche, Inc.
    Inventors: Alvaro Morales, Stanley J. Alkemade
  • Patent number: 5759554
    Abstract: The present invention relates to an immunotherapeutic agent that is effective in treating a variety of diseases in animals and humans. More particularly, the present invention is a preparation of a modified mycobacterial cell wall extract that does not contain oil, that is capable of stimulating the immune system of an animal or human in such a way as to cause the body to neutralize, abort or eliminate infections, tumors and other disorders.
    Type: Grant
    Filed: December 9, 1994
    Date of Patent: June 2, 1998
    Assignee: Vetrepharm, Inc.
    Inventors: Stanley J. Alkemade, Thomas C. Buckley, Graeme McRae
  • Patent number: 5632995
    Abstract: The present invention relates to an immunostimulant composition and method of use that is effective for increasing reproductive performance in an animal or human. More particularly, the present invention is the use of a mycobacterial cell wall preparation for stimulating the immune system of an animal or human in such a way as to cause an increase in reproductive performance of the animal or human.
    Type: Grant
    Filed: April 4, 1995
    Date of Patent: May 27, 1997
    Assignee: Vetrepharm, Inc.
    Inventors: Jose M. Wade, Stanley J. Alkemade
  • Patent number: 5591724
    Abstract: A method of treating interstitial cystitis comprising contacting the internal bladder and associated structures in a mammal having interstitial cystitis with a solution containing hyaluronic acid having a molecular weight of not less than approximately 2.times.10.sup.5 Daltons in a concentration effective to treat the interstitial cystitis.
    Type: Grant
    Filed: February 14, 1995
    Date of Patent: January 7, 1997
    Assignee: Bioniche Inc.
    Inventors: Alvaro Morales, Stanley J. Alkemade
  • Patent number: 5102783
    Abstract: The present invention includes a composition and method for culturing and freezing cells and tissues without serum or serum products in the culture medium by substituting hyaluronic acid for the serum or serum products. The composition and method are especially well-suited for culturing and freezing embryos, ova and sperm. The present invention reduces the risk of transmittal of microorganisms such as viruses.
    Type: Grant
    Filed: January 12, 1990
    Date of Patent: April 7, 1992
    Assignee: Vetrepharm, Inc.
    Inventors: Stanley J. Alkemade, Andre Palasz, Reuben J. Mapletoft